Patient- oriented approach to management of patients with hepatic cirrhosis
https://doi.org/10.31146/1682-8658-ecg-192-8-142-149
Abstract
Aim of the study: Optimization of medical care to patients with liver cirrhosis (LC) based on using of patient- oriented approach in real clinic practice
Materials and methods: The reviews of 734 medical histories of patients treated in polyclinics and in-patient facilities of general specialization (surgery, therapy) and died from HL in 2015–2019 years in Krasnodar region were analyzed. The experience of regular medical check-up of 85 patients with LC who underwent mini-invasive surgeries was summarized.
Results: The number of mistakes in treatment tactics of patients with LC was revealed. The experience of regular medical check-up and schools for patients with LC was summarized.
Conclusion: Regular medical check-up of patients with LC in multi- disciplinary clinic with practice in mini-invasive surgeries and liver transplantation, attendance of schools for patients improves stabilization and in some cases treatment course of disease.
About the Authors
N. V. Korochanskaya
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Natalia V. Korocanskaya, doctor of Med.Sci. Head of gastroenterological centre, Professor of the Department of surgery Nr 3
Krasnodar
V. M. Durleshter
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Vladimir M. Durleshter, doctor of Med.Sci., Professor, Head of the Department of surgery Nr 3, Deputy director of Chief doctor in surgery
Krasnodar
S. N. Serikova
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Svetlana N. Serikova, doctor of Med.Sci. Head of gastroenterological centre SCOT, Associate Professor of the Department of surgery Nr 3
Krasnodar
O. A. Usova
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Olga A. Usova, gastroenterologist of the Department of gastroenterology
Krasnodar
M. A. Bacenko
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Mikail A. Bacenko, resident doctor of of the Department of surgery Nr 3
Krasnodar
S. S. Serikov
FSBEI HE “Kuban state medical university MHC RF”; SBIHC “Region clinic hospital N 2” MHC of Krasnodar region
Russian Federation
Russian Federation
Stanislav S. Serikov, student
Krasnodar
References
1. Ivashkin V.T., Mayevskaya M. V., Pavlov C. S., Fe dosyina Y. A., Bessonova Y. N., Pirogova I. Yu., Garbuzenko D. V. Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientifi c Liver Society and Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(4):71–102. (In Russ.) doi: 10.22416/1382–4376– 2016–26–4–71–102
2. Anisimov A. Yu., Vertkin A. L., Devyatov A. V., et al. Kli ni cheskie rekomendacii po lecheniyu krovotechenij iz varikozno rasshirennyh ven pishchevoda i zheludka [Clinic manual for treatment of bleeding from esophageal and gastric varicose veins dilatation] (Adopted at AllRussian conciliatory conference once the National clinic recommendations in place “Bleeding from upper parts of gastro- intestinal tract”, Voronej, 5–6 June 2014. Russian society of surgeons, Association of hepato- pancreatobilliar surgeons of CIS–Commonwealth of Independent States). Moscow– Voronej, 2014. 46 p. (in Russ.)
3. European Association for the Study of the Liver; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 2018, no.69, pp.406–60. Doi: 10.1016/j.jhep.2018.03.024.
4. Garcia- Tsao G., Abraldes J. G., Berzigotti A., Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratifi cation, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310–35. Doi: 10.1002/hep.28906.
5. de Franchis R, Editor. Portal Hypertension VI. Procee dings of the VIth Baveno international consensus workshop. New York, USA: Springer, 2015, 420p.
6. Tripathi D., Stanley A. J., Hayes P. C., et al. Transjugular intrahepatic portosystemic stent- shunt in the management of portal hypertension. Gut. 2020, pp. 1–20. doi:10.1136/gutjnl-2019–320221
7. Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev. 2012;8: CD004544
8. Dudanova O.P., Pavlyukova I. P., Larina N. A., Shu bina M. E., Rodina A. S. Etiology and clinical features of acute-on-chronic liver failure in patients with acute decompensation of liver cirrhosis. Experimental and Clinical Gastroenterology. 2019;(8):41–47. (In Russ.) doi: 10.31146/1682–8658-ecg-168–8–41–47
9. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014, no. 11, ppe1001624.
10. Volk ML, Fisher N, Fontana RJ. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol. 2013, no.108, pp302–305.
11. Patel AA, Walling AM, Ricks- Oddie J, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017, no.15, pp1612–1619.e4.
12. Khan A, Tansel A, White DL, et al. Effi cacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin Gastroenterol Hepatol. 2016, no.14, pp191–202.e1–4; quiz e20.
13. Tinetti ME, Naik AD, Dodson JA. Moving from diseasecentered to patient goals–directed care for patients with multiple chronicconditions: Patient value- based care. JAMA Cardiol. 2016, no.1, pp.9–10.
14. Lukina Yu.V., Martsevich S. Yu., Kutishenko N. P. MoriskiGreen scale: positive and negative moments of universal test, errors correction. Rational Farmakotherapy in Cardiology. 2016;12(1): 63–65. (in Russ.)
15. Tapper E, Kanwal F, Asrani S, Ho C, Ovchinsky N, Po teru cha J. Patient reported outcomes in cirrhosis: a scoping review of the literature. Hepatology. 2018, No.67, pp2375–2383.
16. Olevskaya E.R., Dolgushina A. I., Tarasov A. N., Hihlo va A. O. Comorbidity patients with liver cirrhosis: effect on course and outcome. Experimental and Clinical Gastroenterology. 2018;(9):57–63. (In Russ.) doi: 10.31146/1682–8658-ecg-157–9–57–63
17. Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016, no.63, pp.574–580.
18. Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf). 2018, no.6, pp.13–20.
19. Chaudhary N, Lucero C., Villanueva G., Poles M, Gillespie C., Zabar S, Weinshel E. Assessment of abilities of gastroenterology fellows to provide information to patients with liver disease. Clinical Gastroenterology and Hepatology. 2015, no.7, pp.1095–1123.
Review
For citations:
Korochanskaya N.V., Durleshter V.M., Serikova S.N., Usova O.A., Bacenko M.A., Serikov S.S. Patient- oriented approach to management of patients with hepatic cirrhosis. Experimental and Clinical Gastroenterology. 2021;(8):142-149. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-192-8-142-149
Views:
417
Email this article 